Table 1 Treatment characteristics: treatment approach, number of treated tumors, 90Y administered activity, the percentage of lung shunt fraction, tumor to non-tumor liver activity concentration ratio, and volumes for individual tumors (average ± SD), aggregated tumoral liver, target normal liver, and whole normal liver
Patient | Treatment approach | Number of tumors | 90Y Activity (GBq) | LSF (%) | TNR | \( {V}_{T_i} \) (mL) | VTL (mL) | \( {V}_{N{L}_t} \) (mL) | VNLw (mL) |
|---|---|---|---|---|---|---|---|---|---|
1 | Whole-liver | 4 | 1.4 | 6.1 | 1.0 | 143 ± 155 | 573 | 1875 | 1785 |
2 | Lobar | 2 | 1.3 | 1.4 | 0.6 | 2 ± 1 | 4 | 789 | 1235 |
3 | Lobar | 1 | 1.2 | 10.1 | 0.8 | 12 | 12 | 969 | 1509 |
4 | Whole-liver | 50 | 1.8 | 4.0 | 1.2 | 15 ± 33 | 735 | 2277 | 2277 |
5 | Lobar | 3 | 0.6 | 10.7 | 1.2 | 6 ± 1 | 18 | 410 | 1434 |
6 | Lobar | 1 | 0.5 | 6.6 | 0.6 | 93 | 93 | 932 | 1551 |
7 | Whole-liver | 9 | 0.9 | 1.8 | 1.7 | 6 ± 6 | 50 | 1176 | 1176 |
8 | Lobar | 1 | 1.1 | 9.0 | 2.3 | 282 | 282 | 982 | 1577 |
9 | Lobar | 2 | 1 | 3.9 | 2.3 | 13 ± 6 | 26 | 753 | 1240 |
10 | Lobar | 4 | 0.9 | 2.2 | 1.5 | 10 ± 5 | 42 | 887 | 1725 |
11 | Whole-liver | 15 | 1.6 | 5.3 | 2.2 | 12 ± 17 | 177 | 1605 | 1605 |
12 | Segmental | 2 | 1 | 4.1 | 1.4 | 14 ± 1 | 29 | 472 | 1205 |
13 | Lobar | 1 | 1.8 | 3.6 | 1.2 | 130 | 129 | 1003 | 1561 |
14 | Whole-liver | 6 | 1.3 | 5.8 | 0.7 | 82 ± 53 | 493 | 1373 | 1373 |